[HTML][HTML] Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: recommendations of the Advisory Committee on Immunization Practices …

JL Liang - MMWR. Recommendations and reports, 2018 - cdc.gov
This report compiles and summarizes all recommendations from CDC's Advisory Committee
on Immunization Practices (ACIP) regarding prevention and control of tetanus, diphtheria …

[HTML][HTML] Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women—Advisory …

M Sawyer, JL Liang, N Messonnier… - Morbidity and Mortality …, 2013 - ncbi.nlm.nih.gov
Methods In monthly teleconferences during 2012, the ACIP Pertussis Vaccines Work Group
considered published, peer-reviewed literature and unpublished data relevant to …

[HTML][HTML] Use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines: updated recommendations of the Advisory Committee on Immunization …

FP Havers - MMWR. Morbidity and mortality weekly report, 2020 - cdc.gov
Background Two Tdap vaccines are licensed for use in the United States. Boostrix
(GlaxoSmithKline) is approved for a single dose in persons aged≥ 10 years; Adacel (Sanofi …

Novel approaches to reactivate pertussis immunity

G Blanchard-Rohner - Expert Review of Vaccines, 2022 - Taylor & Francis
Introduction Whole cell and acellular pertussis vaccines have been very effective in
decreasing the deaths of neonates and infants from Bordetella pertussis. Despite high …

Vaccination practices in dialysis patients: A narrative review

G Kosmadakis, J Albaret, EDC Correia… - Seminars in …, 2018 - Wiley Online Library
In a period of turmoil concerning vaccination practices, there is a serious conflict between
scientifically reasonable, evidence‐based guidelines and the far‐fetched rumors or …

Antiviral responses induced by Tdap-IPV vaccination are associated with persistent humoral immunity to Bordetella pertussis

J Gillard, M Suffiotti, P Brazda… - Nature …, 2024 - nature.com
Many countries continue to experience pertussis epidemics despite widespread vaccination.
Waning protection after booster vaccination has highlighted the need for a better …

A decennial booster dose of reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix™) is immunogenic and well tolerated in adults

R Booy, O Van Der Meeren, SP Ng, F Celzo… - Vaccine, 2010 - Elsevier
Reduced-antigen-content diphtheria–tetanus–acellular-pertussis (dTpa) vaccines are
predominantly recommended for once-in-a-lifetime use. A second dTpa (Boostrix™ …

Immune responses in adults to revaccination with a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine 10 years after a previous dose

SA Halperin, D Scheifele, G De Serres, F Noya… - Vaccine, 2012 - Elsevier
BACKGROUND: Although decennial adult boosters of tetanus and diphtheria toxoids are
recommended in Canada and the United States, a second dose of pertussis vaccine during …

Impact and cost-effectiveness of a second tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine dose to prevent pertussis in the United …

H Kamiya, BH Cho, ML Messonnier, TA Clark, JL Liang - Vaccine, 2016 - Elsevier
Abstract Introduction The United States experienced a substantial increase in reported
pertussis cases over the last decade. Since 2005, persons 11 years and older have been …

Randomized controlled trial of the safety and immunogenicity of revaccination with tetanus-diphtheria-acellular pertussis vaccine (Tdap) in adults 10 years after a …

SA Halperin, C Donovan, GS Marshall… - Journal of the …, 2019 - academic.oup.com
Background Reduced-antigen-content tetanus, diphtheria, and acellular pertussis (Tdap)
vaccine is recommended in many countries for boosting immunity in adolescents and adults …